TrialJournal of gastroenterology2014

Baseline factors and very early viral response (week 1) for predicting sustained virological response in telaprevir-based triple combination therapy for Japanese genotype 1b chronic hepatitis C patients: a multicenter study.

Noritomo Shimada et al.PubMed ↗Publisher ↗

No numbers read from the abstract.